Man Group
GBT

Man Group’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Man Group’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-639,097
Closed -$43.5M – 2357
2022
Q3 		$43.5M Buy
+639,097
New +$35.2M 0.2% 117
2021
Q2 		– Sell
-17,610
Closed -$718K – 2149
2021
Q1 		$718K Sell
17,610
-60,543
-77% -$2.78M ﹤0.01% 1386
2020
Q4 		$3.38M Buy
78,153
+32,052
+70% +$1.58M 0.01% 987
2020
Q3 		$2.54M Sell
46,101
-30,256
-40% -$1.92M 0.01% 1111
2020
Q2 		$4.82M Buy
76,357
+66,757
+695% +$4.58M 0.02% 684
2020
Q1 		$490K Sell
9,600
-6,965
-42% -$467K ﹤0.01% 1286
2019
Q4 		$1.32M Sell
16,565
-38,488
-70% -$2.28M ﹤0.01% 1438
2019
Q3 		$2.67M Buy
+55,053
New +$2.87M 0.01% 1147
2019
Q2 		– Sell
-38,887
Closed -$2.06M – 2054
2019
Q1 		$2.06M Buy
+38,887
New +$1.91M 0.01% 1323
2018
Q4 		– Sell
-7,901
Closed -$300K – 2180
2018
Q3 		$300K Sell
7,901
-1,027
-12% -$45.5K ﹤0.01% 1952
2018
Q2 		$403K Sell
8,928
-20,094
-69% -$915K ﹤0.01% 1855
2018
Q1 		$1.4M Buy
+29,022
New +$1.62M 0.01% 1400

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Man Group's GBT Position: Q4 2022 in Review

Man Group sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 639,097 shares — an estimated $43.5M sold.

Man Group first reported a position in GBT in Q1 2018 and held it in 12 quarters. The position peaked at $43.5M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Man Group reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Man Group sold 639,097 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $43.5M.
  • Man Group first reported a position in Global Blood Therapeutics, Inc. in Q1 2018 and held it in 12 quarters.
  • Man Group's Global Blood Therapeutics, Inc. position peaked at $43.5M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Man Group's 13F filing for Q4 2022, filed 14 Feb 2023.